🕵️ Genelux Corp ($GNLX)
SEC insider & ownership activity, last 12 months · CIK 1231457 · every row links its SEC filing
Over the last 12 months insiders sold $277K with no open-market buying against it. Thomas John sold $109K through a 10b5-1 trading plan in 3 lots (Dec–Jun). Aladar Szalay trimmed 8.4% → 8.2%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 6 sellers, $277K (25 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Thomas John | 0 | – | 3 | $109K | Jun 1, 2026 |
| Zindrick Thomas | 0 | – | 4 | $83K | May 11, 2026 |
| John W. Smither | 0 | – | 1 | $35K | Jul 1, 2026 |
| Yu Yong | 0 | – | 4 | $20K | May 11, 2026 |
| Cappello Joseph | 0 | – | 5 | $18K | May 11, 2026 |
| Smalling Ralph | 0 | – | 8 | $12K | Jun 3, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 10.0% | 13G | Nov 14, 2025 | filing ↗ | |
| Steven Boyd | 10.0% | 13G | Nov 14, 2025 | filing ↗ | |
| Aladar Szalay | 8.2% | 13G | Feb 17, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| John Smither | $35K | Jul 1, 2026 | filing ↗ |
| Johnny Thomas | $30K | Jun 1, 2026 | filing ↗ |
| Johnny Thomas | $30K | Mar 2, 2026 | filing ↗ |
| Johnny Thomas | $56K | Dec 1, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | Jun 16, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 19, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 2, 2026 | filing ↗ |
| Other events (8.01) | Jan 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 8, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 5, 2026 | filing ↗ |
| Other events (8.01) | Jan 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 30, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 30, 2025 | filing ↗ |
| Officer/director changes (5.02) | Aug 27, 2025 | filing ↗ |
| Shareholder vote (5.07) | Aug 27, 2025 | filing ↗ |